Aspen Neuroscience
Private
Services: Develops iPSC-derived autologous cell replacement therapies for Parkinson disease and other neurological conditions
Company Info
Upcoming Milestones & Key Dates
Q3/Q4 2026
Earnings
Q2 2026 corporate update
Recent News
No recent news updates available for this company.
Leadership Team
Careers & Job Openings